Description
Genomtec ID is a flagship technological solution currently under development, which will offer patients ultrafast mobile genetic diagnosis utilizing SNAAT®. The Genomtec ID platform makes it possible to run a diagnostic process at point of care, i.e., public clinics, consulting rooms, hospital, pharmacies and emergency wards, without the need of complicated and time-consuming handling by skilled personnel in the laboratory.
The platform includes an analyzer and reaction card with integrated genetic tests and provides multiplexing capability of up to five genetic targets at the same time. SARS-CoV-2 will be included in one of the Genomtec ID’s diagnostic panels intended for identification of respiratory diseases.